Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michele Laudisi
Response to Ibrutinib of a Refractory IgA Lymphoplasmacytic Lymphoma Carrying the MYD88 L265P Gene Mutation
Mediterranean Journal of Hematology and Infectious Diseases
Infectious Diseases
Hematology
Related publications
IGHV Gene Features and MYD88 L265P Mutation Separate the Three Marginal Zone Lymphoma Entities and Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphomas
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
IgA-producing Lymphoplasmacytic Lymphoma Carrying the Chromosomal Abnormality T(8;14)
Journal of clinical and experimental hematopathology : JCEH
Medicine
Ibrutinib Therapy for Lymphoplasmacytic Lymphoma
American Journal of Hematology
Hematology
Schnitzler Syndrome Associated With MYD88 L265P Mutation
JAAD Case Reports
Dermatology
L265P Mutation of the MYD88 Gene Is Frequent in Waldenström’s Macroglobulinemia and Its Absence in Myeloma
PLoS ONE
Multidisciplinary
MYD88 L265P Is a Marker Highly Characteristic Of, but Not Restricted To, Waldenström’s Macroglobulinemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Integrated Stress Response and Immune Cell Infiltration in an Ibrutinib-Refractory Mantle Cell Lymphoma Patient Following ONC201 Treatment
British Journal of Haematology
Hematology
Phase Ib/Ii Study of Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Obinutuzumab Plus Ibrutinib in Relapse/Refractory Mantle Cell Lymphoma Patients: First Results of the Oasis Phase I Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
